GNL Gut and Liver
  1. Sarah Wieczorkiewicz, RaeAnna Zatarski. Adherence to and Outcomes Associated with aClostridium difficileGuideline at a Large Teaching Institution. Hospital Pharmacy 2015;50:042
    https://doi.org/10.1310/hpj5001-042
  2. Claire Nour Abou Chakra, Jacques Pepin, Stephanie Sirard, Louis Valiquette, Daniel Paredes-Sabja. Risk Factors for Recurrence, Complications and Mortality in Clostridium difficile Infection: A Systematic Review. PLoS ONE 2014;9:e98400
    https://doi.org/10.1371/journal.pone.0098400
  3. Emma Meader, Melinda J. Mayer, Dietmar Steverding, Simon R. Carding, Arjan Narbad. Evaluation of bacteriophage therapy to control Clostridium difficile and toxin production in an in vitro human colon model system. Anaerobe 2013;22:25
    https://doi.org/10.1016/j.anaerobe.2013.05.001
  4. Abhishek Deshpande, Vinay Pasupuleti, Priyaleela Thota, Chaitanya Pant, David D.K. Rolston, Adrian V. Hernandez, Curtis J. Donskey, Thomas G. Fraser. Risk Factors for Recurrent Clostridium difficile Infection: A Systematic Review and Meta-Analysis. Infect. Control Hosp. Epidemiol. 2015;36:452
    https://doi.org/10.1017/ice.2014.88
  5. Young Seok Doh, You Sun Kim, Hye Jin Jung, Young Il Park, Jin Won Mo, Hyun Sung, Kyung Jin Lee, Young Ki Seo, Jeong Seop Moon, Seong Woo Hong. Long-Term Clinical Outcome ofClostridium difficileInfection in Hospitalized Patients: A Single Center Study. Intest Res 2014;12:299
    https://doi.org/10.5217/ir.2014.12.4.299
  6. Anna Wentz Sams, Laurie Kennedy-Malone. Recognition and management of Clostridium difficile in older adults. 2017;42:50
    https://doi.org/10.1097/01.NPR.0000512254.47992.8e
  7. Imad M. Tleyjeh, Aref A. Bin. Abdulhak, Muhammad Riaz, Musa A. Garbati, Mohamad Al-Tannir, Faisal A. Alasmari, Mushabab AlGhamdi, Abdur Rahman Khan, Patricia J. Erwin, Alex J. Sutton, Larry M. Baddour, Adrian V. Hernandez. The Association between Histamine 2 Receptor Antagonist Use and Clostridium difficile Infection: A Systematic Review and Meta-analysis. PLoS ONE 2013;8:e56498
    https://doi.org/10.1371/journal.pone.0056498
  8. Jen-Chieh LEE, Chun-Wei CHIU, Pei-Jane TSAI, Ching-Chi LEE, I-Hsiu HUANG, Wen-Chien KO, Yuan-Pin HUNG. Clostridium butyricum therapy for mild-moderate Clostridioides difficile infection and the impact of diabetes mellitus. 2022;41:37
    https://doi.org/10.12938/bmfh.2021-049
  9. Nader S. Abutaleb, Mohamed N. Seleem. In vivo efficacy of auranofin in a hamster model of Clostridioides difficile infection. Sci Rep 2021;11
    https://doi.org/10.1038/s41598-021-86595-3
  10. Hui-Qi Qu, Zhi-Dong Jiang. Clostridium difficile infection in diabetes. Diabetes Research and Clinical Practice 2014;105:285
    https://doi.org/10.1016/j.diabres.2014.06.002
  11. Ji Won Kim. Risk Factors for Delayed Recurrence ofClostridium difficileInfection. Intest Res 2014;12:266
    https://doi.org/10.5217/ir.2014.12.4.266
  12. Han Seung Ryu, Yong Sung Kim, Geom Seog Seo, Yu Min Lee, Suck Chei Choi. Risk Factors for RecurrentClostridium difficileInfection. Intest Res 2012;10:176
    https://doi.org/10.5217/ir.2012.10.2.176
  13. Titilope O. Olanipekun, Jason L. Salemi, Maria C. Mejia de Grubb, Sandra J. Gonzalez, Roger J. Zoorob. Clostridium difficile infection in patients hospitalized with type 2 diabetes mellitus and its impact on morbidity, mortality, and the costs of inpatient care. Diabetes Research and Clinical Practice 2016;116:68
    https://doi.org/10.1016/j.diabres.2016.04.021
  14. R. Mulki, A. J. Baumann, T. Alnabelsi, N. Sandhu, Y. Alhamshari, D. S. Wheeler, S. Perloff, P. O. Katz. Body mass index greater than 35 is associated with severe Clostridium difficile infection. Aliment Pharmacol Ther 2017;45:75
    https://doi.org/10.1111/apt.13832
  15. Konstantinos Z. Vardakas, Konstantinos A. Polyzos, Konstantina Patouni, Petros I. Rafailidis, George Samonis, Matthew E. Falagas. Treatment failure and recurrence of Clostridium difficile infection following treatment with vancomycin or metronidazole: a systematic review of the evidence. International Journal of Antimicrobial Agents 2012;40:1
    https://doi.org/10.1016/j.ijantimicag.2012.01.004
  16. Eduardo Sanchez, Elizabeth M Krantz, Zahra Kassamali Escobar, Frank Tverdek, Emily A Rosen, Masumi Ueda Oshima, Paul A Carpenter, Steven A Pergam, Catherine Liu. Epidemiology and Outcomes of Recurrent C Difficile Infection Among Hematopoietic Cell Transplant Recipients: A Single-center, Retrospective 10-year Study. 2024;11
    https://doi.org/10.1093/ofid/ofae570
  17. Yuan-Pin Hung, Jen-Chieh Lee, Bo-Yang Tsai, Jia-Ling Wu, Hsiao-Chieh Liu, Hsiu-Chuan Liu, Hsiao-Ju Lin, Pei-Jane Tsai, Wen-Chien Ko. Risk factors of Clostridium difficile-associated diarrhea in hospitalized adults: Vary by hospitalized duration. Journal of Microbiology, Immunology and Infection 2021;54:276
    https://doi.org/10.1016/j.jmii.2019.07.004
  18. E. Bouza. Consequences of Clostridium difficile infection: understanding the healthcare burden. Clinical Microbiology and Infection 2012;18:5
    https://doi.org/10.1111/1469-0691.12064
  19. Nader S. Abutaleb, Mohamed N. Seleem. Auranofin, at clinically achievable dose, protects mice and prevents recurrence from Clostridioides difficile infection. Sci Rep 2020;10
    https://doi.org/10.1038/s41598-020-64882-9
  20. Hee Kyoung Choi, Kye Hyung Kim, Sun Hee Lee, Su Jin Lee. Risk Factors for Recurrence ofClostridium difficileInfection: Effect of Vancomycin-resistant Enterococci Colonization. J Korean Med Sci 2011;26:859
    https://doi.org/10.3346/jkms.2011.26.7.859
  21. Natchaya Polpichai, Sakditad Saowapa, Phuuwadith Wattanachayakul, Pojsakorn Danpanichkul, Hamza Tahir, Monzer Abdalla, Angkawipa Trongtorsak. Impact of diabetic ketoacidosis on outcomes in hospitalized diabetic patients with Clostridioides difficile infection: a national inpatient analysis . Baylor University Medical Center Proceedings 2024;37:742
    https://doi.org/10.1080/08998280.2024.2356782
  22. Sarah Wieczorkiewicz, RaeAnna Zatarski. Adherence to and Outcomes Associated with a Clostridium difficile Guideline at a Large Teaching Institution. Hosp Pharm 2015;50:042
    https://doi.org/10.1310/hpj5001-42
  23. S. Di Bella, C. Nisii, N. Petrosillo. Is tigecycline a suitable option for Clostridium difficile infection? Evidence from the literature. International Journal of Antimicrobial Agents 2015;46:8
    https://doi.org/10.1016/j.ijantimicag.2015.03.012
  24. Wasef Na’amnih, Amos Adler, Tamar Miller-Roll, Dani Cohen, Yehuda Carmeli. Risk factors for recurrent Clostridium difficile infection in a tertiary hospital in Israel. Eur J Clin Microbiol Infect Dis 2018;37:1281
    https://doi.org/10.1007/s10096-018-3247-1
  25. Moacyr Silva Júnior. Recent changes in Clostridium difficile infection. Einstein (São Paulo) 2012;10:105
    https://doi.org/10.1590/S1679-45082012000100023
  26. J.W. Suh, Y.J. Jeong, H.G. Ahn, J.Y. Kim, J.W. Sohn, Y.K. Yoon. Epidemiologic characteristics and risk factors of Clostridioides difficile infection in patients with active tuberculosis in the Republic of Korea: a nationwide population-based study. Journal of Hospital Infection 2024;154:1
    https://doi.org/10.1016/j.jhin.2024.07.019
  27. Jieun Kim, Hyunjoo Pai, Mi-ran Seo, Jung Oak Kang. Epidemiology and Clinical Characteristics ofClostridium difficileInfection in a Korean Tertiary Hospital. J Korean Med Sci 2011;26:1258
    https://doi.org/10.3346/jkms.2011.26.10.1258
  28. Claudia Vuotto, Ines Moura, Fabrizio Barbanti, Gianfranco Donelli, Patrizia Spigaglia, Tom Coenye. Subinhibitory concentrations of metronidazole increase biofilm formation inClostridium difficilestrains. Pathogens and Disease 2016;74:ftv114
    https://doi.org/10.1093/femspd/ftv114
  29. Mohamed Abdelfatah, Rabih Nayfe, Ala Nijim, Kathleen Enriquez, Eslam Ali, Richard R. Watkins, Hossam Kandil. Factors Predicting Recurrence of Clostridium difficile Infection (CDI) in Hospitalized Patients: Retrospective Study of More than 2000 Patients. Journal of Investigative Medicine 2015;63:747
    https://doi.org/10.1097/JIM.0000000000000188
  30. Chenjie Tang, Yang Li, Chengcheng Liu, Pengfei Sun, Xu Huang, Wenying Xia, Huimin Qian, Lunbiao Cui, Genyan Liu. Epidemiology and risk factors for Clostridium difficile–associated diarrhea in adult inpatients in a university hospital in China. American Journal of Infection Control 2018;46:285
    https://doi.org/10.1016/j.ajic.2017.08.020
  31. Claire M.F. van Nispen tot Pannerden, Annelies Verbon, Ernst J. Kuipers. Recurrent Clostridium difficile Infection. Drugs 2011;71:853
    https://doi.org/10.2165/11591230-000000000-00000
© 2023. Gut and Liver. / Powered by INFOrang Co., Ltd